Company intelligence / Profile preview

A1 Imports

Ownership: Private
Employees: ~13
Development stage: Commercial

Overview

A1 Life Sciences manufactures in vitro diagnostic products, including a portfolio of PCR-based assays for COVID‑19 diagnosis and variant detection. Their Diagnovital kits are used globally to identify SARS-CoV‑2 mutations and variants, supporting public health efforts to track the pandemic. They have a monthly manufacturing capacity of 3 million units for six different COVID‑19 products. No clinical trial results are reported as these are diagnostics.

Therapeutic areas: Infectious Diseases
Modalities: Diagnostic kitIn vitro diagnostic product
Industry: Molecular Diagnostics

Partnerships

Siemens Healthineers (global distribution partnership for Diagnovital kits)

Beyond the preview

Go deeper on A1 Imports.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on A1 Imports.

Explore the full profile